Management of advanced prostate cancer

被引:6
|
作者
Kaliks, Rafael A.
Del Giglio, Auro
机构
[1] Hematology and Oncology Center for Studies and Research, ABC School of Medicine, SP
[2] Santo André - SP 09060-650
来源
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2008年 / 54卷 / 02期
关键词
prostatic neoplasms/therapy; hormones/therapeutic use; hormonal antineoplastic agents; drug therapy; epidemiology;
D O I
10.1590/S0104-42302008000200025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Geriatricians and general practitioners often follow patients with metastatic prostate cancer, The epidemiology and basic treatment principles of metastatic prostate cancer are discussed aiming to update the topic for the non-oncologist. Hormone manipulation remains the basis of treatment, usually up to a second line of therapy. Selected cases are treated successfully with intermittent androgen ablation, When new hormone-independent clones arise, chemotherapy should be added to therapy that confers improved survival as well as better quality of life when based on taxanes. In specific situations, additional measures such as bisphosphonates and radiation therapy should be included in the treatment. As a rule, the public health system makes available the necessary medication to ensure treatment for the vast majority of patients in Brazil.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 50 条
  • [11] The management of locally advanced prostate cancer
    Valicenti, RK
    PROSTATE CANCER AND PROSTATIC DISEASES, 2002, 5 (Suppl 2) : S8 - S11
  • [12] Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
    Gillessena, Silke
    Attard, Gerhardt
    Beer, Tomasz M.
    Beltran, Himisha
    Bjartell, Anders
    Bossi, Alberto
    Briganti, Alberto
    Bristow, Rob G.
    Chi, Kim N.
    Clarke, Noel
    Davis, Ian D.
    de Bono, Johann
    Drake, Charles G.
    Duran, Ignacio
    Eeles, Ros
    Efstathiou, Eleni
    Evans, Christopher P.
    Fanti, Stefano
    Feng, Felix Y.
    Fizazi, Karim
    Frydenberg, Mark
    Gleave, Martin
    Halabi, Susan
    Heidenreich, Axel
    Heinrich, Daniel
    Higano, Celestia S.
    Hofman, Michael S.
    Hussain, Maha
    James, Nicolas
    Kanesvaran, Ravindran
    Kantoff, Philip
    Khauli, Raja B.
    Leibowitz, Raya
    Logothetis, Chris
    Maluf, Fernando
    Millman, Robin
    Morgans, Alicia K.
    Morris, Michael J.
    Mottet, Nicolas
    Mrabti, Hind
    Murphy, Declan G.
    Murthy, Vedang
    Oh, William K.
    Ost, Piet
    OSullivan, Joe M.
    Padhani, Anwar R.
    Parker, Chris
    Poon, Darren M. C.
    Pritchard, Colin C.
    Reiter, Robert E.
    EUROPEAN UROLOGY, 2020, 77 (04) : 508 - 547
  • [13] Management strategies for locally advanced prostate cancer
    Jani, AB
    DRUGS & AGING, 2006, 23 (02) : 119 - 129
  • [14] Debating controversies in the management of advanced prostate cancer
    Payne, Heather A.
    Dearnaley, David
    Troup, Janis
    TRENDS IN UROLOGY & MENS HEALTH, 2011, 2 (04) : 39 - 41
  • [15] Contemporary hormonal management of advanced prostate cancer
    Moul, JW
    ONCOLOGY-NEW YORK, 1998, 12 (04): : 499 - 505
  • [16] Management Strategies for Locally Advanced Prostate Cancer
    Ashesh B. Jani
    Drugs & Aging, 2006, 23 : 119 - 129
  • [17] Integration of immunotherapy into the management of advanced prostate cancer
    Kantoff, Philip
    Higano, Celestia S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (05) : S41 - S47
  • [18] Management of advanced prostate cancer in elderly patients
    Bompas, Emmanuelle
    Dedecker, Laure
    BULLETIN DU CANCER, 2012, 99 : S21 - S29
  • [19] The role of corticoids in the management of advanced prostate cancer
    Gonzalez-del-Alba Baamonde, Aranzazu
    Sevillano Fernandez, Elena
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (03): : 281 - 287
  • [20] Management and survival in advanced prostate cancer in Nairobi
    Magoha, GAO
    EAST AFRICAN MEDICAL JOURNAL, 2000, 77 (05) : 260 - 263